There were 2,389 press releases posted in the last 24 hours and 359,563 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Verrica Pharmaceuticals Achieves Positive Topline Results in Phase 2 Clinical Study of VP-102 in Patients with Common Warts

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image